| Ytd | -33.50% | |
| 1y | -2.89% |
| Open | 11.46 | Prev Close | 11.35 | Low | 11.31 | High | 11.75 | Mkt Cap | 831.64M |
| Vol | 46.32K | Avg Vol | 10.30K | EPS | 0.16 | P/E | 73.44 | Forward P/E | 216.49 |
| Beta | -0.01 | Short Ratio | 0.38 | Inst. Own | 0.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-31 | 50-d Avg | 12.71 | 200-d Avg | 15.36 | 1yr Est | 34.35 |
Pharming Group told investors to expect up to $425 million in 2026 revenue. The Company now expects
Ratio Petroleum Energy has raised its recommended offer for Pharos Energy (LSE:PHAR) to 32.8183p per
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder righ
Law Offices of Howard G. Smith announces an investigation on behalf of Pharming Group N.V. (âPharm
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Pharmin
Pharming Group shares fell 22% on July 30, 2026 after the Company reported a Q2 revenue decline and
A 22% single-session drop hit Pharming Group (PHAR) shares today after the Company reported Q2 2026
NEW YORK--(BUSINESS WIRE)--A 22% single-session drop hit Pharming Group (PHAR) shares today after th
Leiden, the Netherlands, August 4, 2026: Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHA
Pharming Group's legacy product RUCONEST posted a 10% year-over-year sales decline in Q2 2026 -- and
Pharming Group N.V. (PHAR) Q2 2026 Earnings Call Transcript
Pharming Group NASDAQ: PHAR reported second-quarter revenue of $90.2 million, down 3% from a year ea
Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session.
U.S. stock futures rise, Meta shares drop 9.4%, Teladoc Health and Rentokil Initial fall after mixed
Shares of Pharming Group N.V. Sponsored ADR (NASDAQ: PHAR - Get Free Report) have earned a consensus
If approved, Joenja will be the first approved treatment in the U. S. for children with activated ph
Pharming Group announced that shareholders approved all proposals presented at its Annual General Me
Pharming Group NASDAQ: PHAR executives said first-quarter 2026 results reflected an expected decline
Pharming Group N.V. (PHAR) Q1 2026 Earnings Call Transcript
U.S. stock futures up, Dow futures gain 0.1% as Snap (NYSE: SNAP) shares fall 10.5%, Fastly (NASDAQ:
Shares of Kulicke & Soffa Industries (NASDAQ: VECO) rose after beating earnings estimates. Other
Leiden, the Netherlands, May 7, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Am
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for it
Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnin
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings
Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announc
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for